Literature DB >> 12164955

A new prebiotic from germinated barley for nutraceutical treatment of ulcerative colitis.

Tadao Bamba1, Osamu Kanauchi, Akira Andoh, Yoshihide Fujiyama.   

Abstract

A germinated barley foodstuff (GBF) containing glutamine-rich protein and hemicellulose-rich fiber was made from brewer's spent grain, by physical isolation. Our previous studies demonstrated that GBF supported maintenance of epithelial cell populations, facilitated epithelial repair, and suppressed epithelial nuclear factor kappaB-DNA-binding activity through generating increased short-chain fatty acid (especially butyrate) production by luminal microflora, which includes Bifidobacterium and Eubacterium, thereby preventing experimental colonic injury. The fiber fraction also modulates stool water content because of its high water-holding capacity. The patients with mild to moderate active ulcerative colitis who had been unresponsive to or intolerant of standard treatment received 20-30 g GBF, feeding daily in a non-randomized, open-label fashion. At 4 weeks, this treatment resulted in a significant clinical and endoscopic improvement. The improvement was associated with an increase in stool butyrate concentrations. These results indicate that GBF feeding is a potentially new, attractive prebiotic treatment in patients with ulcerative colitis. The potency of GBF on modulating microflora, as well as the high water-holding capacity, may play an important role in treatment and prolongation of remission in ulcerative colitis.

Entities:  

Mesh:

Year:  2002        PMID: 12164955     DOI: 10.1046/j.1440-1746.2002.02709.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  15 in total

1.  Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing.

Authors:  Y Okada; Y Tsuzuki; J Miyazaki; K Matsuzaki; R Hokari; S Komoto; S Kato; A Kawaguchi; S Nagao; K Itoh; T Watanabe; S Miura
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

2.  Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis.

Authors:  Yasushi Yoshimatsu; Akihiro Yamada; Ryuichi Furukawa; Koji Sono; Aisaku Osamura; Kentaro Nakamura; Hiroshi Aoki; Yukiko Tsuda; Nobuo Hosoe; Nobuo Takada; Yasuo Suzuki
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 3.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 4.  Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.

Authors:  Antonella Gallo; Giovanna Passaro; Antonio Gasbarrini; Raffaele Landolfi; Massimo Montalto
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

5.  Probiotics for maintenance of remission in ulcerative colitis.

Authors:  Zipporah Iheozor-Ejiofor; Lakhbir Kaur; Morris Gordon; Patricia Anne Baines; Vasiliki Sinopoulou; Anthony K Akobeng
Journal:  Cochrane Database Syst Rev       Date:  2020-03-04

6.  Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial.

Authors:  Osamu Kanauchi; Toshihiro Suga; Masahiro Tochihara; Toshifumi Hibi; Makoto Naganuma; Terasu Homma; Hitoshi Asakura; Hiroshi Nakano; Kazuya Takahama; Yoshihide Fujiyama; Akira Andoh; Takashi Shimoyama; Nobuyuki Hida; Ken Haruma; Hideki Koga; Keiichi Mitsuyama; Michio Sata; Masanobu Fukuda; Atsushi Kojima; Tadao Bamba
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

Review 7.  Diet and nutritional factors in inflammatory bowel diseases.

Authors:  Danuta Owczarek; Tomasz Rodacki; Renata Domagała-Rodacka; Dorota Cibor; Tomasz Mach
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

Review 8.  Role of Short Chain Fatty Acids and Apolipoproteins in the Regulation of Eosinophilia-Associated Diseases.

Authors:  Eva Maria Sturm; Eva Knuplez; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

Review 9.  Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility.

Authors:  Franco Scaldaferri; Viviana Gerardi; Loris Riccardo Lopetuso; Fabio Del Zompo; Francesca Mangiola; Ivo Boškoski; Giovanni Bruno; Valentina Petito; Lucrezia Laterza; Giovanni Cammarota; Eleonora Gaetani; Alessandro Sgambato; Antonio Gasbarrini
Journal:  Biomed Res Int       Date:  2013-08-07       Impact factor: 3.411

10.  Prebiotic treatment reduced preneoplastic lesions through the downregulation of toll like receptor 4 in a chemo-induced carcinogenic model.

Authors:  Masanobu Fukuda; Yutaka Komiyama; Keiichi Mitsuyama; Akira Andoh; Takahiko Aoyama; Yoshiaki Matsumoto; Osamu Kanauchi
Journal:  J Clin Biochem Nutr       Date:  2011-05-14       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.